These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
115 related articles for article (PubMed ID: 471989)
21. Tuberculosis chemotherapy and sputum conversion among HIV-seropositive and HIV-seronegative patients in south-eastern Uganda. Bwire R; Borgdorff MW; Sticht-Groh V; Rieder HL; Kawuma HJ; Bretzel G; Rüsch-Gerdes S East Afr Med J; 1999 Jun; 76(6):307-13. PubMed ID: 10750516 [TBL] [Abstract][Full Text] [Related]
22. [Efficiency of an intensive stage of chemotherapy for tuberculosis in elderly and senile patients]. Karachunskiĭ MA; Uvarova TE Probl Tuberk Bolezn Legk; 2004; (3):19-21. PubMed ID: 15338894 [TBL] [Abstract][Full Text] [Related]
23. [Long-term results of treatment for drug-resistant pulmonary tuberculosis in socially adapted patients]. Khodashova ML; Iuditskiĭ MV; Semenova OV Probl Tuberk Bolezn Legk; 2004; (3):26-8. PubMed ID: 15338896 [TBL] [Abstract][Full Text] [Related]
24. Liposome-based antitubercular drug therapy in a guinea pig model of tuberculosis. Pandey R; Sharma S; Khuller GK Int J Antimicrob Agents; 2004 Apr; 23(4):414-5. PubMed ID: 15081096 [No Abstract] [Full Text] [Related]
25. [Use of regional lymphotropic therapy in the treatment of pulmonary tuberculosis in HIV-infected individuals]. Panteleev AM; Ivanov AK; Vinogradova EN Probl Tuberk Bolezn Legk; 2004; (6):26-8. PubMed ID: 15315127 [TBL] [Abstract][Full Text] [Related]
31. [Controlled trial of isoniazid.rifampicin.ethambutol regimen and isoniazid.rifampicin.pyrazinamide regimen in the primary chemotherapy for pulmonary tuberculosis (author's transl)]. Kekkaku; 1980 Jan; 55(1):7-13. PubMed ID: 6988627 [No Abstract] [Full Text] [Related]
32. [Endocavernous treatment of caverns with atypical Mycobacteria]. Neef W Z Erkr Atmungsorgane Folia Bronchol; 1970 Jun; 131(5):385-9. PubMed ID: 5210837 [No Abstract] [Full Text] [Related]
33. [Antituberculosis chemotherapy including ofloxacin in patients with pulmonary tuberculosis not treated previously]. Tsukamura M; Yoshii S; Yasuda Y; Saito H Kekkaku; 1986 Jan; 61(1):15-7. PubMed ID: 3458966 [No Abstract] [Full Text] [Related]
34. Two excellent management tools for national tuberculosis programmes: history of prior treatment and sputum status at two months. Trébucq A; Rieder HL Int J Tuberc Lung Dis; 1998 Mar; 2(3):184-6. PubMed ID: 9526189 [No Abstract] [Full Text] [Related]
35. [Fully supervised ambulatory short-course chemotherapy with an intermittent regimen for newly diagnosed smear-positive pulmonary tuberculosis]. Xu RX Zhonghua Jie He He Hu Xi Za Zhi; 1987 Oct; 10(5):261-3, 307. PubMed ID: 3131029 [No Abstract] [Full Text] [Related]
36. Intermittent chemotherapy or improvement of initial treatment in tuberculosis. Oka S Sci Rep Res Inst Tohoku Univ Med; 1971 Jul; 18(1):1-6. PubMed ID: 4949334 [No Abstract] [Full Text] [Related]
37. [Enhancing treatment efficiency of patients with pulmonary tuberculosis by regional lymphotropic therapy]. Ubaĭdullaev AM; Belotserkovskiĭ VG Probl Tuberk; 1999; (6):14-6. PubMed ID: 10715948 [TBL] [Abstract][Full Text] [Related]
38. [Short-term treatment of tuberculosis with and without pyrazinamide in the second phase (TA-80)]. Farga V; Valenzuela P; Yañez A; Valenzuela MT; Scheel G; Mendoza F; Torres E; Icekson I; Grinspun M; Fernández M Rev Med Chil; 1983 Jul; 111(7):750-4. PubMed ID: 6680460 [No Abstract] [Full Text] [Related]
39. [The clinical and pharmacokinetic features of lymphotropic therapy in patients with new-onset pulmonary tuberculosis]. Priakhina VN; Kolpakov MA; Kolpakov AR; Zyrianova TV; Mokhina OG Probl Tuberk Bolezn Legk; 2005; (6):55-8. PubMed ID: 16078725 [TBL] [Abstract][Full Text] [Related]
40. [Controlled intermittent chemotherapy with isoniazid and the second line preparations]. Utkin VV; Zhukova GN; Shmeleva VI Probl Tuberk; 1975; (6):22-6. PubMed ID: 1215343 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]